1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA POLE4 CTRPv2 pan-cancer AAC -0.14 1e-05
mRNA MVB12B CTRPv2 pan-cancer AAC 0.14 1e-05
mRNA LAMTOR1 CTRPv2 pan-cancer AAC -0.14 1e-05
mRNA GIGYF1 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA C3orf62 CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA IGF2BP2 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA SPATS2L CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA ZNF286A CTRPv2 pan-cancer AAC 0.15 1e-05
mRNA PPP1R3D CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA LGALS3 CTRPv2 pan-cancer AAC -0.16 1e-05
Download CSV